1,914
Views
19
CrossRef citations to date
0
Altmetric
Brain tumour

FGF2 as a potential prognostic biomarker for proneural glioma patients

, , , , , , , , , , , & show all
Pages 385-394 | Received 24 Mar 2014, Accepted 16 Jul 2014, Published online: 29 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Jimenez-Pascual, Kelly Mitchell, Florian A Siebzehnrubl & Justin D Lathia. (2020) FGF2: a novel druggable target for glioblastoma?. Expert Opinion on Therapeutic Targets 24:4, pages 311-318.
Read now

Articles from other publishers (18)

Zikuan Zhang, Bo Wu, Yuan Shao, Yongquan Chen & Dongwen Wang. (2022) A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer. PLOS ONE 17:12, pages e0278556.
Crossref
Zhanxin Du, Yaqing Wang, Jiaqi Liang, Shaowei Gao, Xiaoying Cai, Yu Yu, Zhihui Qi, Jing Li, Yubin Xie & Zhongxing Wang. (2022) Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis. Computational and Structural Biotechnology Journal 20, pages 5203-5217.
Crossref
Lina Leiss, Ercan Mutlu, Mohummad Aminur Rahman, Mette Hartmark Nilsen & Per Øyvind Enger. 2022. Biomarkers of the Tumor Microenvironment. Biomarkers of the Tumor Microenvironment 509 518 .
Wei Zhang, You Zhai, Guanzhang Li & Tao Jiang. (2021) A novel gene signature based on five immune checkpoint genes predicts the survival of glioma. Chinese Neurosurgical Journal 7:1.
Crossref
Takamasa Kinoshita, Hiroyuki Tomita, Hideshi Okada, Ayumi Niwa, Fuminori Hyodo, Tomohiro Kanayama, Mikiko Matsuo, Yuko Imaizumi, Takahiro Kuroda, Yuichiro Hatano, Masafumi Miyai, Yusuke Egashira, Yukiko Enomoto, Noriyuki Nakayama, Shigeyuki Sugie, Kazu Matsumoto, Yu Yamaguchi, Masayuki Matsuo, Hideaki Hara, Toru Iwama & Akira Hara. (2021) Endothelial cell-specific reduction of heparan sulfate suppresses glioma growth in mice. Discover Oncology 12:1.
Crossref
Martina Takacova, Ivana Kajanova, Maria Kolarcikova, Jana Lapinova, Miriam Zatovicova & Silvia Pastorekova. (2022) Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: a case of carbonic anhydrase IX. Cancer and Metastasis Reviews 40:4, pages 1035-1053.
Crossref
Junxu Lu, Yuanbo Wang, Yanuan Hu & Biaobing Yang. (2021) WITHDRAWN: Lnc-H19 enhances anaerobic glycolysis of keloid fibroblasts by targeting the miR-214-5p/FGF2 axis. Burns.
Crossref
Pei Wei, Zhainan Zhang, Mao Lin, Bin Zhou & Zhiyong Wang. (2020) Bevacizumab has bidirectional regulatory effects on the secretion of basic fibroblast growth factor in glioma cells. Cytokine 129, pages 155022.
Crossref
Bhavesh K. Ahir, Herbert H. Engelhard & Sajani S. Lakka. (2020) Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma. Molecular Neurobiology 57:5, pages 2461-2478.
Crossref
Gang Wu, Xinghui Song, Jun Liu, Shize Li, Weiqin Gao, Mingxing Qiu, Changjin Yang, Yiming Ma & Yuhong Chen. (2020) Expression of CD44 and the survival in glioma: a meta-analysis. Bioscience Reports 40:4.
Crossref
Xiaori Huang, Lei Wang, Wei Liu & Fei Li. (2019) MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2. Oncology Letters.
Crossref
Ruichao Chai, Kenan Zhang, Kuanyu Wang, Guanzhang Li, Ruoyu Huang, Zheng Zhao, Yanwei Liu & Jing Chen. (2018) A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Journal of Cancer Research and Clinical Oncology 144:3, pages 439-447.
Crossref
Fachen Wang, Hui Jiang, Shanjun Wang & Bing Chen. (2017) Dual Functional MicroRNA-186-5p Targets both FGF2 and RelA to Suppress Tumorigenesis of Glioblastoma Multiforme. Cellular and Molecular Neurobiology 37:8, pages 1433-1442.
Crossref
Sonja Schötterl, Miriam Hübner, Angela Armento, Vivien Veninga, Naita Maren Wirsik, Simon Bernatz, Hans Lentzen, Michel Mittelbronn & Ulrike Naumann. (2017) Viscumins functionally modulate cell motility-associated gene expression. International Journal of Oncology 50:2, pages 684-696.
Crossref
Feng Wang, Lijun Yang, Jianping Sun, Jun Zheng, Lin Shi, Gengshen Zhang & Na Cui. (2017) Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2. Molecular BioSystems 13:7, pages 1345-1354.
Crossref
Kenney R. Roodakker, Tamador Elsir, Per-Henrik D. Edqvist, Daniel Hägerstrand, Joseph Carlson, Malgorzata Lysiak, Roger Henriksson, Fredrik Pontén, Johan Rosell, Peter Söderkvist, Roger Stupp, Elena Tchougounova, Monica Nistér, Annika Malmström & Anja Smits. (2016) PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. Oncotarget 7:45, pages 72431-72442.
Crossref
Nobuhisa Takase, Yu-ichiro Koma, Naoki Urakawa, Mari Nishio, Noriaki Arai, Hiroaki Akiyama, Manabu Shigeoka, Yoshihiro Kakeji & Hiroshi Yokozaki. (2016) NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells. Cancer Letters 380:1, pages 47-58.
Crossref
Simon J. A. van Kuijk, Ala Yaromina, Ruud Houben, Raymon Niemans, Philippe Lambin & Ludwig J. Dubois. (2016) Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis. Frontiers in Oncology 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.